Literature DB >> 7757162

Are the respiratory health effects found in manufacturers of ceramic fibres due to the dust rather than the exposure to fibres?

P S Burge1, I A Calvert, W N Trethowan, J M Harrington.   

Abstract

OBJECTIVES: To determine whether the respiratory symptoms and decrements in lung function found in manufacturers of ceramic fibres are related to exposure to the respirable fibre or inspirable mass constituents of the air in the working environment.
METHODS: Cross sectional survey of all current European primary producers of ceramic fibre was carried out, with measurement of exposure to respiratory fibres by personal samplers that measured inspirable and total mass, together with a health survey with an expanded respiratory questionnaire and standardised measurement of lung function. Odds ratios were calculated for symptoms and current exposure by multiple logistic regression, and multiple linear regression coefficients for lung function related to cumulative exposures controlled for the effects of respirable fibre and inspirable mass separately and together.
RESULTS: Significant effects of current exposure to both inspirable dust and respirable fibres were related to dry cough, stuffy nose, eye and skin irritation and breathlessness. The decrements found in smokers and to some extent in ex-smokers in forced expiratory volume in one second and forced expiratory flow from 25% to 75% of expiratory volume, seem to be related to the respirable fibres rather than the inspirable mass constituents of the environment.
CONCLUSIONS: Current symptoms were related to both current exposure to inspirable dust and respirable fibre. The decrements in lung function were related to the fibre constituent of the exposure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7757162      PMCID: PMC1128163          DOI: 10.1136/oem.52.2.105

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  4 in total

1.  A new personal sampler for airborne total dust in workplaces.

Authors:  D Mark; J H Vincent
Journal:  Ann Occup Hyg       Date:  1986

2.  Long-term health effects in hamsters and rats exposed chronically to man-made vitreous fibres.

Authors:  D M Smith; L W Ortiz; R F Archuleta; N F Johnson
Journal:  Ann Occup Hyg       Date:  1987

3.  Study of the respiratory health of employees in seven European plants that manufacture ceramic fibres.

Authors:  W N Trethowan; P S Burge; C E Rossiter; J M Harrington; I A Calvert
Journal:  Occup Environ Med       Date:  1995-02       Impact factor: 4.402

4.  Carcinogenicity of fibrous glass: pleural response in the rat in relation to fiber dimension.

Authors:  M F Stanton; M Laynard; A Tegeris; E Miller; M May; E Kent
Journal:  J Natl Cancer Inst       Date:  1977-03       Impact factor: 13.506

  4 in total
  4 in total

1.  An epidemiological study of the respiratory health of workers in the European refractory ceramic fibre industry.

Authors:  H A Cowie; P Wild; J Beck; G Auburtin; C Piekarski; N Massin; J W Cherrie; J F Hurley; B G Miller; S Groat; C A Soutar
Journal:  Occup Environ Med       Date:  2001-12       Impact factor: 4.402

Review 2.  Perspectives on refractory ceramic fiber (RCF) carcinogenicity: comparisons with other fibers.

Authors:  Helmut Greim; Mark J Utell; L Daniel Maxim; Ron Niebo
Journal:  Inhal Toxicol       Date:  2014-09-29       Impact factor: 2.724

3.  Biomarkers for Pulmonary Inflammation and Fibrosis and Lung Ventilation Function in Chinese Occupational Refractory Ceramic Fibers-Exposed Workers.

Authors:  Xiaojun Zhu; Yishuo Gu; Wenjun Ma; Panjun Gao; Mengxuan Liu; Pei Xiao; Hongfei Wang; Juan Chen; Tao Li
Journal:  Int J Environ Res Public Health       Date:  2017-12-27       Impact factor: 3.390

4.  Assessment of Pulmonary Function Parameters, Signs, and Symptoms in the Employee of a Dairy Products Company in Tehran, Iran.

Authors:  Mohammad Hassan Nassiri-Kashani; Mashallah Aghilinejad; Amir Bahrami-Ahmadi; Omid Moslemi; Elahe Kabir-Mokamelkhah
Journal:  Tanaffos       Date:  2018-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.